ArticleWorld journal of surgical oncology2022

TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy.

Xiaoyu Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.